Mount Sinai’s School Of Medicine To Launch Biomedical Blockchain Research Center
Mount Sinai’s, “The Icahn School of Medicine and the Institute for Next Generation Healthcare”, recently made the announcement that a blockchain-based research center will be implemented to address the use of the technology within the medical field. In particular, the key focus is to see whether or not artificial technology can help to improve areas such as EHRs, medical necessities like wearables and drug development to name a few.
Healthcare IT News has conveyed that the head of the new research center will be none other than Joel Dudley, who serves as the Executive Vice President at Mount Sinai’s Precision Health. Dudley seems to approve blockchain technology, as he remains hopeful that the tech can serve multiple uses in the field of biomedicine.
He openly expressed that,
“Many companies are already exploring the use of blockchain technologies in biology and healthcare.” As for the entirety of the project at hand, Dudley shared that the goal behind the research center is to explore the ways in which blockchain “can be applied to unmet needs in healthcare and biomedicine.”
Mount Sinai’s eager to participate within the blockchain industry is supposedly a collaboration of 144 companies that are working towards the same goal – blockchain-based healthcare solutions. As reported by Coindesk, some of the companies include CoverUs, a platform that rewards users for taking care of themselves and Embleema, a healthcare-driven blockchain platform. Crain’s also noted that the participating firms have raised a combined $670 million as funds for the project through initial coin offerings (ICO) and venture capital (VC).